Jul 30

Could Ryan Braun Be A Fit For Mets?

Kudos to Milwaukee owner Mark Attanasio for his immediate gesture to Brewers fans in the wake of the 65-game suspension of Ryan Braun. But, will it end there? Could the Brewers want to clean up their mess by trading Braun? And if so, could the Mets be a fit?

BRAUN: What is his future? (Getty)

BRAUN: What is his future? (Getty)

Yes, Braun got off on a technicality the first time and Major League Baseball has had it in for him since. It was only a matter of time before they nailed him. Could it also be a matter of time before the Brewers decide to cut ties with Braun?

The Brewers’ best player lied to his teammates, management, fans and anybody he spoke to about performance-enhancing drugs. The quotes from players and supporters – including Packers quarterback Aaron Rodgers – have been venomous.

With Braun gone for the season and the Brewers stagnant on the field, the team will give each fan who shows up at Milwaukee’s 12 home games in August a $10 voucher good for food, merchandise and future tickets.

“This is an investment in our fans and an investment in our brand, to do what we can do to mitigate a trying summer,’’ Brewers chief operating officer Rick Schlesinger told the Milwaukee Journal-Sentinel. “We were finalizing something like this to give back to our loyal fans just as news of Ryan’s suspension hit. Mark decided he wanted to make a dramatic impact that would cost more money.’’

Based on their current attendance figures, it is estimated the Brewers will give their fans roughly $3.6 million in vouchers, or effectively a good chunk of the remaining $8.5 million they were to pay Braun this year. Instead of pocketing the money, the Brewers are giving it to their fans.

This is no cheap gesture.

What happens when Braun returns is anybody’s guess. He might be booed or Brewers’ fans could forgive and forget. It remains to be seen how strained his relationship with ownership and management might be. His presence could also create a clubhouse divide. There are not a lot of people happy with Braun now, including those players mentioned in the Biogenesis case. By taking a punishment without appeal, it gives credibility to Tony Bosch, which could hurt the defenses of other players.

Schlesinger spoke of the Brewers’ brand. Currently, that brand is mostly Braun, and the wonder is if they want to continue with that considering the potential of stress and negativity.

Could that strain lead to an eventual trade, and would the Mets be interested? Braun is a talented player, but with a positive test – albeit tainted – there’s the question of his true talents. It must be that way with any player linked to steroids.

Braun to the Mets is intriguing on many levels. He would be a huge upgrade, but what is his value? The asking price can’t be as high if Braun were clean. What would it require to get him in terms of talent, and would the Mets risk it based on his PED history? Would the Mets, or any team that wanted Braun, know what they are getting? The Brewers must be asking the same question if they opt to keep him.

Braun signed a five-year, $105-million contract extension from 2016-2020, and an option for 2021. That’s reasonable money for what Braun has produced, but it must be asked whether that production is he or the juice.

It would be a significant gamble by the Mets because of the length of Braun’s deal and the chance of paying for damaged goods. The Mets don’t have to look any further than across town to see what the Yankees are going through with Alex Rodriguez.

Going after Braun could generate a negative buzz around the Mets, but that’s better than no buzz.

As always, your comments are greatly appreciated and I will attempt to answer them. Follow me on Twitter @jdelcos

Jul 23

Has The Players Association Lost Its Teeth?

Is the Baseball Players Association, usually regarded as professional sports’ most powerful union, no more? Perhaps not as toothless as the impotent unions representing players in football, basketball and hockey, but in light of the Biogenesis disgrace that’s the impression.

Director Michael Weiner’s recent comments the MLBPA would not stand in the way of Biogenesis suspensions – with Ryan Braun’s for the remainder of the 2013 season the first – is not representative of a vibrant union.

The union’s rap was it would defend an ax murderer, but there is a minimum understanding in the reasoning for such a reputation. The union’s job is to not only enhance its members’ financial position, but also defend them against often overzealous owners.

While it is understandable and admirable of Commissioner Bud Selig for wanting to eradicate performance-enhancing drugs from the sport, the terms of Major League Baseball’s drug policy was defined by collective bargaining.

Selig’s heart is in the right place in wanting to clean his sport, despite that he and the owners initially looked the other way during the height of the Mark McGwire-Sammy Sosa steroid-fueled home run chase in 1998, and subsequent shameful acceptance of Barry Bonds’ assault on Hank Aaron’s true home run record.

The policy has checks and balances and an appeals process, one Braun utilized and skated on a technicality. Braun beat the suspension because a MLB handler made a mistake. The process was in place to enable Braun to walk.

It is a process designed to avoid a witch-hunt and unfair prosecution of a player. I have no sympathy for a cheater and as a Hall of Fame voter will not vote for player linked to steroids. I want steroids gone from the sport, but want them eliminated the right way.

The Biogenesis case has been ugly from the start, with the evidence more than circumstantial against Braun, Alex Rodriguez and others. However, MLB did not have subpoena powers to obtain records from Biogenesis owner Tony Bosch, who for a price, since went to bed with Selig against the players.

That’s distasteful and creates the impression of Selig being vindictive against Braun for beating the first suspension. It was undoubtedly embarrassing for Selig and MLB to lose that case, but it was a sign the drug policy was working.

For MLB’s drug policy to continue to work it must have an appeals process and the players can’t be denied due process. Weiner should not accept MLB’s case against the Biogenesis players without question and simply taking Selig’s word, especially with him having to purchase the evidence against players from Bosch, whose reputation is certainly not above reproach.

There have been eight work stoppages in baseball, the last one the 1994 strike forced on the players by the owners for their refusal to bargain in good faith on the issues of revenue sharing and a salary cap. This one bled into two seasons and forced Selig to sack the World Series. After that, it was hoped the two sides learned something as to never have another stoppage, and after a near miss in 2002, that turned out to be the case.

However, did peace come at the price of the MLBPA selling out to Selig and the owners? For all practical purposes, Selig has his salary cap. And, if the MLBPA gives in without a hint of due process, in what other areas will the union capitulate?

And, how healthy is that to baseball’s growth?

ON DECK: About Last Night: Not liking Bobby Parnell’s response.

As always, your comments are greatly appreciated and I will attempt to answer them. Please follow me on Twitter @jdelcos

Jun 28

Mets Should Explore Trading Ike Davis To Yankees

Why is Ike Davis still in Triple-A Las Vegas when the New York Mets should be exploring all their options, including trading him to the Bronx?

With Mark Teixeira out for the remainder of the season after re-injuring his wrist, and with a good chance the Mets won’t tender Davis in the off-season and let him walk, shouldn’t two plus two equal four?

DAVIS: Mets should be talking to Yanks about him.

DAVIS: Mets should be talking to Yanks about him.

The Yankees remain contenders despite not having Teixeira, Derek Jeter, Alex Rodriguez and Curtis Granderson. Who knows if, and when, they’ll return? In the interim, Davis might give them a boost.

The Yankees’ offense has been as barren as the Mets’ have been, but because of their starting pitching, Mariano Rivera and a fast start, they are still a potential force in the AL East.

However, they are in need of a first baseman and a bat. Travis Hafner can no longer play first and his bat has cooled considerably. You’d think the Yankees would jump at the chance to add a left-handed power hitter such as Davis, who is making a little over $3 million.

That would be a very easy contract for the Yankees to pick up, and if it doesn’t work out they can always non-tender Davis this winter. Either way, does anybody really expect to see Davis in Flushing in 2014?

Davis is starting to hit in Vegas and was recently named the Pacific Coast Player of the Week. I can see him salivating at the opportunity to hit at Yankee Stadium.

Despite Davis’ rising numbers in Vegas, the Mets are reluctant to bring him up, citing facing a pair of left-handers against both the Nationals and Diamondbacks in their upcoming homestand at Citi Field. That should tell you something about the Mets’ feelings regarding Davis. If they thought he has found it, he’d be heading on a plane to New York.

Perhaps, the Yankees can see the same thing in Davis. However, they aren’t dealing from a position of strength, and desperate times could mean the desperate measure of trading for Davis.

Davis appears to have worn out his welcome with the Mets, while Phil Hughes and Joba Chamberlain are reportedly done after this year with the Yankees. They won’t get both, but I’d trade Davis for Hughes even-up in a heartbeat.

A change of scenery could work for all concerned. This could work with some tweaking.

Sandy Alderson should be on the phone with Brian Cashman, and soon.

As always, your comments are greatly appreciated and I will attempt to answer them. Please follow me on Twitter @jdelcos

Jun 17

Where Does Jordany Valdespin Fit In With Mets?

Should the New York Mets pull the plug on the Jordany Valdespin experiment, manager Terry Collins and management will be able to look in the mirror and say they tried.

They would be fooling themselves.

VALDESPIN: What is his future? (Getty)

VALDESPIN: What is his future? (Getty)

A week is clearly not enough for most players to come off the bench to make a solid statement at second base, or any other position for that matter. They might give Valdespin more time, but it won’t be a significant chance because the Mets don’t even know if they want him to play second base.

Valdespin is 3-for-23 at the plate and hasn’t been effective in the field. If second is his natural position, he’s in trouble. Then again, Daniel Murphy didn’t have a natural position and it has taken him nearly two years to get a feel for the position.

The Mets are going out of order in the Valdespin experiment. The first issue isn’t whether they think he can play second, but whether they want him in the organization in the first place. Next, is where do they envision Valdespin playing? And, who is his competition in the organization?

In the short term, it is Murphy, but if he’s their “real second baseman of the future” they never should have been playing him at first this past week. The time should have gone to first baseman Josh Satin to get an idea what they have in him.

On the minor league level, the Mets’ seventh-ranked prospect is Wilmer Flores, who is a natural third baseman. However, with David Wright signed long-term, the Mets are playing Flores at second base. Finding a place for him is a higher priority than finding a place for Valdespin.

If Flores is the second baseman of the future, it stands to reason neither is Valdespin nor Murphy – so they must be showcasing the latter. Flores could be tested at shortstop, but Cal Ripken, Derek Jeter and Alex Rodriguez were all tall, lanky and strong shortstops, so that’s not a real argument if they want to look at Flores over Ruben Tejada.

The Mets seem to have two second base options – three if they consider moving Tejada back – ahead of Valdespin, so what exactly are they trying to find out?

They definitely can’t learn much in a week enough to showcase him in a trade, especially with his previous baggage. They have a better chance of building Valdespin’s value it they play him in the minor leagues every day for the next mont than if he played part time on the major league level.

There’s clearly room for Valdespin in the outfield; there’s room for a lot of options in the outfield.

If the Mets decide they want Valdespin a part of their future, they will eventually find him a spot if he can hit. And, save a handful of pinch-hit homers, what do they know about this guy offensively?

They know he has pop and can occasionally drive a ball.  However, from his limited 116-at-bats window the first impression is he’s undisciplined, which makes one wonder outside of his speed what are his attributes as a leadoff hitter.

Overall, Valdespin is hitting .207, but more concerning is .a 264 on-base percentage. Valdespin swings from his heels and often at breaking stuff away in the dirt. His 24 strikeouts-to-six walks ratio is alarming, and for all his speed, four steals to three times being caught is barely a wash.

I don’t know if, or where, Valdespin will fit in with the Mets two or three years from now. I don’t think the Mets know, either. Fact is, I’m not sure the Mets know where Valdespin will fit in a month from now.

As always, your comments are greatly appreciated and I will attempt to answer them. Please follow me on Twitter @jdelcos

Jun 06

Major League Baseball’s Case Against Rodriguez And Braun Not Ironclad

What I want to see is the Mets play as compelling and emotional game as the Boston Bruins played last night. However, as it is with the Mets’ luck, it isn’t surprising that the Major League Baseball war against PED users in the Biogenesis case is set to explode at the All-Star Game.

It will be interesting to see how Major League Baseball spins off the Home Run Derby as its lawyers are running to court and back.

It is admirable Bud Selig wants to clean up the sport he allowed to get sullied by looking at steroid usage in the first place; how he tried to buy back the good will of the fans he alienated by killing off the 1994 World Series in the owner-initiated work stoppage with the chemically-enhanced Mark McGwire-Sammy Sosa home run chase.

Caving under the pressure of attendance drops coupled by the criticism from the not-knowing that the game is too boring, Selig sold out for the quick fix of the home run.

That decision, along with the interleague play gimmick – also in the wake of the work stoppage – will forever be Selig’s legacy as commissioner.

Now, add the Biogenesis case.

Major League Baseball is seeking to suspend 20 players for connection to Biogenesis founder Tony Bosch, but its primary guns are aimed at Alex Rodriguez and Ryan Braun, who have made a mockery of the sport’s drug policy.

Rodriguez, who admitted using steroids for only a three-year period while with Texas and not with the Yankees, has repeatedly denied using again. Braun tested positive after his MVP season, but escaped punishment on a technicality.

Major League Baseball has been fuming since and this is coming off as the vendetta it is rather than a simple cleansing act.

While the picture looks bleak for Rodriguez and Braun, Major League Baseball shouldn’t celebrate too soon, as a sharp lawyer will attempt to turn this around.

Bosch initially refuted MLB’s request to turn over his records – he had no legal obligation to do so – and only is cooperating with Selig dropping the lawsuit against him. It was a lawsuit Bosch arguably could have won if he was able to afford to go against Major League Baseball’s deep pockets.

Bosch’s decision to go to bed with MLB came after Rodriguez refused to give him financial support, one of the few smart things the troubled Yankees’ third baseman has done in recent years.

It looks as if Bosch is turning on Rodriguez because he is, and that appearance doesn’t look good for Major League Baseball, which, when it comes to PEDs, has looked bad before Congress, and couldn’t put away Roger Clemens or Barry Bonds.

The technicality in which Braun escaped might be valid, but the sport comes off as a sore loser in not winning in arbitration.

If Selig wants to play hardball against PED users, that’s great, but there are other ways, and he will need the backing of the Players Association, which can’t be happy about this case. Instead, Major League Baseball is putting all its eggs in the Bosch basket, and he hasn’t been reputable from the start.

As always, your comments are greatly appreciated and I will attempt to answer them. Please follow me on Twitter @jdelcos